Magnetic field desensitizes 5-HT1B receptor in brain: pharmacological and functional studies
暂无分享,去创建一个
Jacques Lambrozo | G. Fillion | F. Deschamps | J. Lambrozo | O. Massot | B. Grimaldi | Olivier Massot | Brigitte Grimaldi | Jean-Marc Bailly | Magali Kochanek | François Deschamps | Gilles Fillion | J. Bailly | M. Kochanek
[1] E. Parker,et al. Characterization of human 5-HT1 receptors expressed in Sf9 insect cells. , 1994, European journal of pharmacology.
[2] R. Belmaker,et al. Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[3] B Conrad,et al. Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease. , 1999, Neuroreport.
[4] R. Belmaker,et al. Transcranial magnetic stimulation: A potential new frontier in psychiatry , 1995, Biological Psychiatry.
[5] C. Epstein,et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[6] T. Zyss,et al. The influence of rapid-rate transcranial magnetic stimulation (rTMS) parameters on rTMS effects in Porsolt's forced swimming test. , 1999, The international journal of neuropsychopharmacology.
[7] B. Jacobs,et al. An animal behavior model for studying central serotonergic synapses. , 1976, Life sciences.
[8] C. Nemeroff,et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.
[9] R. Sandyk,et al. The association of diabetes mellitus with dementia in Parkinson's disease. , 1992, The International journal of neuroscience.
[10] M. Frye,et al. Beyond Lithium in the Treatment of Bipolar Illness , 1998, Neuropsychopharmacology.
[11] S H Lisanby,et al. Transcranial Magnetic Stimulation Applications in Neuropsychiatry , 1999 .
[12] W. Paulus,et al. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats , 1999, Brain Research.
[13] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[14] R. Post,et al. Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. , 1999, The journal of ECT.
[15] R. Post,et al. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[16] M. Hallett,et al. Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression , 1996, Neurology.
[17] R. Sandyk. Magnetic fields in the therapy of parkinsonism. , 1992, The International journal of neuroscience.
[18] Mark Hallett,et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression , 1995, Neuroreport.
[19] Grahame-Smith Dg. Serotonin in affective disorders. , 1992 .
[20] J. Hyttel,et al. Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[21] M. Moskowitz,et al. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis , 1999, Neuropharmacology.
[22] C M Epstein,et al. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] W. R. Adey,et al. Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Klein,et al. Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain , 1999, Brain Research.
[25] R. Belmaker,et al. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression , 1995, Brain Research.
[26] C. Cotman,et al. Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. , 1971, Biochimica et biophysica acta.
[27] Á. Pascual-Leone,et al. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression , 1996, The Lancet.
[28] T. Kenakin. The classification of seven transmembrane receptors in recombinant expression systems. , 1996, Pharmacological reviews.
[29] J. Bockaert,et al. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. , 1988, European journal of pharmacology.
[30] R. Hen,et al. 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. , 1997, Molecular pharmacology.
[31] M Feinsod,et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. , 1999, Archives of general psychiatry.
[32] R Kavet,et al. Depressive symptoms and headaches in relation to proximity of residence to an alternating-current transmission line right-of-way. , 1993, American journal of epidemiology.
[33] M. Moskowitz,et al. Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin , 1995, British journal of pharmacology.
[34] R. Belmaker,et al. Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia , 1996, Biological Psychiatry.
[35] L. Siever,et al. Critical issues in defining the role of serotonin in psychiatric disorders. , 1991, Pharmacological reviews.
[36] M Feinsod,et al. Preliminary evidence for a beneficial effect of low‐frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia , 1998, Depression and anxiety.
[37] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .
[38] M. Moskowitz,et al. CP‐93,129, sumatriptan, dihydroergotamine block c‐fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges , 1992, British journal of pharmacology.
[39] M Hallett,et al. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[40] C. Londos,et al. A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.
[41] M. Repacholi. Low-level exposure to radiofrequency electromagnetic fields: health effects and research needs. , 1998, Bioelectromagnetics.
[42] M. Moskowitz,et al. Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. , 1999, European journal of pharmacology.